相关实验视频
Updated: Jul 1, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.6K
第1型糖尿病:十年来关于植物疗法的临床前研究的教训
Ahmad Ghorbani1, Leila Mobasheri2, Seyed Mostafa Moshirian Farahi3
1Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Fitoterapia
|March 12, 2024
概括
关于1型糖尿病 (T1D) 草药的临床前研究显示出有希望的结果,但由于方法上的局限性,结果往往无法转化为人类临床试验. 本综述指导研究人员改善研究设计和可复制性,以获得可靠的T1D植物疗法研究.
科学领域:
- 植物疗法 植物疗法
- 第1型糖尿病研究研究
- 临床前研究设计
背景情况:
- 许多草药产品在动物模型中显示出抗高血糖和β细胞再生作用.
- 缺乏支持这些草药产品在治疗人类1型糖尿病 (T1D) 的疗效的临床证据.
- 这表明植物化学物质可能不会显著影响人类β细胞,限制实验结果的概括性.
研究的目的:
- 进行一项关于1型糖尿病 (T1D) 植物疗法的临床前研究方法和结果的广泛审查.
- 批判性地分析过去10年内发表的研究.
- 确定阻碍临床前发现的临床翻译的局限性.
主要方法:
- 对研究设计,治疗方案和糖尿病诱导方法在临床前T1D研究中的批判性分析.
- 动物模型的评估,临床相关性和研究可重复性.
- 讨论影响实验结果对人类临床环境的概括性的限制.
主要成果:
- 许多关于T1D植物疗法的临床前研究存在局限性,这些局限性阻止了其结果对临床实践的概括.
- 在研究设计,方法和报告中发现的缺陷会影响研究结果的可靠性和可重复性.
- 缺乏强有力的临床前证据,挑战了草药化合物所谓的抗糖尿病作用的转化到人类疗法.
结论:
- 该综述为T1D植物疗法研究人员提供了实用指南.
- 提供了建议,以提高临床前研究的可靠性,可重现性和有效性.
- 改善研究方法对于避免误导性解释和推进T1D草药治疗领域至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Pathophysiology of Diabetes
928
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928

